2026 Annual General Meeting of Shareholders

Past Event Cardiol Therapeutics ($CRDL): A New Approach to Treating Inflammation in Heart DiseaseMay 19, 2026

Past Event Cardiol Therapeutics (CRDL) Fireside Chat at the H.C. Wainwright 4th Annual BioConnect Investor Conference at the NASDAQMay 19, 2026

Past Event Ellis Martin: Cardiol Therapeutics (CRDL) CEO David Elsley on Breakthrough Heart Disease TreatmentApr 28, 2026